What is the differential diagnosis for a male patient with secondary hypogonadism, presenting with complete loss of libido, erectile dysfunction, and loss of penile sensation, with normal total testosterone, low free testosterone, inappropriately normal Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) levels, and fluctuating prolactin levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis and Workup for Secondary Hypogonadism with Inappropriately Normal Gonadotropins

This patient has functional hypogonadism—a form of secondary hypogonadism where LH/FSH levels appear "normal" but are inappropriately low relative to the reduced free testosterone, indicating subtle hypothalamic-pituitary axis dysfunction rather than complete failure. 1, 2

Understanding the Biochemical Pattern

The key diagnostic feature here is inappropriately normal LH (6.87 mIU/mL) despite low free testosterone (0.295 nmol/L)—in true eugonadism, low free testosterone should trigger compensatory LH elevation, but this patient's pituitary response is blunted. 1, 3 This distinguishes functional hypogonadism from:

  • Primary hypogonadism: Would show elevated LH/FSH (>12-15 mIU/mL) as the pituitary attempts compensation 1, 4
  • Classical secondary hypogonadism: Would show frankly low LH/FSH (<2 mIU/mL) 1, 3
  • Functional hypogonadism: Shows low-normal gonadotropins that are inadequate for the testosterone level 2

The fluctuating prolactin (69.4 to 9.5 ng/mL) is particularly concerning—the initial elevation suggests intermittent hyperprolactinemia, which directly suppresses GnRH pulsatility. 5

Differential Diagnosis (Prioritized by Likelihood)

Drug-Induced Causes (Most Common—Always Exclude First)

  • Opioid medications: Directly suppress GnRH neurons, causing this exact pattern 5, 3
  • Glucocorticoids: Suppress hypothalamic-pituitary function 5, 4
  • Hyperprolactinemia-inducing drugs: Antipsychotics, metoclopramide, SSRIs 5
  • Anabolic steroids or testosterone: Even remote use can cause prolonged axis suppression 5

Pituitary/Hypothalamic Structural Lesions

  • Prolactinoma or microprolactinoma: The fluctuating prolactin (peak 69.4 ng/mL) strongly suggests this—even microadenomas cause gonadotropin suppression 5, 3
  • Non-functioning pituitary adenoma: Can cause partial gonadotropin deficiency with "normal" but inadequate LH 5, 3
  • Hypothalamic tumors: Germinomas, craniopharyngiomas 5, 6
  • Traumatic brain injury: Even remote head trauma can cause delayed pituitary dysfunction 5
  • Prior pituitary surgery or cranial radiation: Iatrogenic causes 5

Systemic Diseases Causing Functional Hypogonadism

  • Metabolic syndrome/Type 2 diabetes: Obesity and insulin resistance suppress GnRH pulsatility 5, 2
  • Chronic systemic diseases: HIV, chronic kidney disease, liver disease 5
  • Sleep apnea: Causes intermittent hypoxia affecting hypothalamic function 2
  • Chronic inflammatory conditions: Rheumatoid arthritis, inflammatory bowel disease 5

Infiltrative/Inflammatory Disorders

  • Lymphocytic hypophysitis: Autoimmune pituitary inflammation 5
  • Sarcoidosis or granulomatous disease: Can infiltrate hypothalamus/pituitary 5
  • Hemochromatosis: Iron deposition in pituitary 5, 3
  • Langerhans cell histiocytosis 5

Congenital Disorders (Less Likely Given Adult Onset)

  • Adult-onset idiopathic hypogonadotropic hypogonadism: Can present later in life 5, 3
  • Kallmann syndrome variants: Usually presents earlier but mild forms can be delayed 5

Recommended Workup Algorithm

Step 1: Repeat and Expand Hormonal Assessment

  • Repeat morning prolactin (8-10 AM) on 2-3 separate occasions: Single elevated value may be spurious; persistent elevation >25 ng/mL warrants imaging 4, 3
  • Measure SHBG: Calculate free testosterone index (total testosterone/SHBG <0.3 confirms hypogonadism) 4
  • Thyroid function (TSH, free T4): Thyroid disorders alter SHBG and can cause secondary hypogonadism 4
  • Morning cortisol and ACTH: Screen for Cushing syndrome or adrenal insufficiency 5, 4
  • IGF-1: Screen for growth hormone deficiency (often accompanies gonadotropin deficiency in pituitary disease) 3

Step 2: Pituitary MRI with Gadolinium Contrast

Obtain MRI regardless of prolactin level given the clinical picture—even with normal prolactin, structural lesions can cause selective gonadotropin deficiency. 5, 3 Look specifically for:

  • Microadenomas (especially in pituitary stalk region)
  • Macroadenomas compressing normal pituitary
  • Empty sella syndrome
  • Hypothalamic masses
  • Pituitary stalk thickening (infiltrative disease)

Step 3: Comprehensive Medication and Substance Review

  • Document all current and recent medications (past 6-12 months), specifically asking about: 5, 4
    • Opioid analgesics (even intermittent use)
    • Glucocorticoids (including topical, inhaled, intra-articular)
    • Psychotropic medications
    • Anabolic steroids or "supplements"
    • Marijuana (suppresses GnRH)

Step 4: Screen for Systemic Conditions

  • Metabolic assessment: Fasting glucose, HbA1c, lipid panel, BMI, waist circumference 4, 2
  • Complete blood count: Anemia suggests chronic disease or hemochromatosis 4
  • Comprehensive metabolic panel: Liver and kidney function 4
  • Iron studies (ferritin, transferrin saturation): Screen for hemochromatosis if family history or elevated ferritin 3
  • Sleep study: If symptoms of sleep apnea (snoring, daytime somnolence) 2

Step 5: Additional Testing Based on Initial Findings

If prolactin remains elevated (>25 ng/mL):

  • Macroprolactin assay: Exclude laboratory artifact 3
  • Visual field testing: If macroadenoma found on MRI 3

If MRI shows pituitary mass:

  • Complete pituitary hormone panel: ACTH, cortisol, TSH, free T4, IGF-1 to assess for hypopituitarism 3, 6

If no structural lesion and no medications identified:

  • GnRH stimulation test: Can differentiate hypothalamic from pituitary dysfunction (though rarely changes management) 6
  • Consider genetic testing: If young age (<30) or family history suggests congenital hypogonadotropic hypogonadism 5

Critical Pitfalls to Avoid

  • Do not dismiss "normal" LH as excluding secondary hypogonadism—inappropriately normal gonadotropins in the setting of low testosterone IS secondary hypogonadism (functional type). 1, 2
  • Do not attribute symptoms to "aging" without full workup—this patient is symptomatic with objective biochemical abnormalities requiring investigation. 7
  • Do not start testosterone therapy before completing workup—testosterone will suppress the axis further, masking underlying pathology and eliminating fertility potential. 1, 4
  • Do not ignore fluctuating prolactin—the peak of 69.4 ng/mL is significant and warrants MRI even if subsequent values normalize. 5
  • Do not overlook medication history—drug-induced hypogonadism is the most common reversible cause and must be systematically excluded. 5, 4

Loss of Penile Sensation: Additional Consideration

The complete loss of penile sensation for 3 years is unusual and suggests possible peripheral neuropathy (diabetic, alcoholic, or other metabolic causes) or neurological pathology independent of hypogonadism. Consider:

  • Neurological examination and nerve conduction studies if metabolic workup negative
  • Spinal MRI if any lower extremity symptoms present
  • This symptom may not resolve with testosterone normalization alone

References

Guideline

LH Differentiation in Hypogonadism Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism.

Journal of endocrinological investigation, 2009

Guideline

Diagnosis and Management of Primary Hypogonadism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Disorders of gonadal function in hypothalamic-pituitary diseases].

Nihon rinsho. Japanese journal of clinical medicine, 1997

Related Questions

Is my recent onset of hypogonadism a new development or has it always been present?
What is the management approach for a male patient with hypogonadism (low sex hormone production) presenting with low Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) levels?
What is the best course of action for a 53-year-old male with hypogonadotropic hypogonadism, as indicated by low FSH (Follicle-Stimulating Hormone) and LH (Luteinizing Hormone) levels, but a normal testosterone level?
What is the diagnosis and treatment for a patient with hypogonadism, indicated by low testosterone, low FSH, and low LH levels?
What is the main difference between hypogonadotropic (low gonadotropin-releasing hormone) hypogonadism and hypergonadotropic (high gonadotropin-releasing hormone) hypogonadism?
What is the next best step in managing a 40-year-old male with newly diagnosed hypertension, currently on Amlodipine (calcium channel blocker) 10mg and Ramipril (angiotensin-converting enzyme inhibitor) 1.25mg, with impaired renal function (eGFR 60), hyperlipidemia (LDL 3.3 mmol/L, non-HDL 3.7 mmol/L), and normal cardiac examination?
When is ANCA (Antineutrophil Cytoplasmic Antibody) testing recommended in patients with IgA (Immunoglobulin A) nephropathy?
How do you differentiate between drowsiness and lethargy in a patient?
What is the recommended dose of metronidazole for a 3-year-old child weighing 11 kg?
What should a 37-year-old patient do after being started on testosterone therapy without proper testing and evaluation?
What is the appropriate management for an adult patient with stenosis of the celiac trunk and risk factors for atherosclerosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.